| GO:0016192 | vesicle-mediated transport | 7.66% (18/235) | 4.23 | 0.0 | 0.0 |
| GO:0051641 | cellular localization | 6.81% (16/235) | 3.81 | 0.0 | 0.0 |
| GO:0005488 | binding | 36.17% (85/235) | 0.97 | 0.0 | 0.0 |
| GO:0015833 | peptide transport | 5.11% (12/235) | 3.51 | 0.0 | 0.0 |
| GO:0051649 | establishment of localization in cell | 5.11% (12/235) | 3.51 | 0.0 | 0.0 |
| GO:0015031 | protein transport | 5.11% (12/235) | 3.51 | 0.0 | 0.0 |
| GO:0042886 | amide transport | 5.11% (12/235) | 3.51 | 0.0 | 0.0 |
| GO:0008104 | protein localization | 5.11% (12/235) | 3.48 | 0.0 | 0.0 |
| GO:0033036 | macromolecule localization | 5.11% (12/235) | 3.48 | 0.0 | 0.0 |
| GO:0045184 | establishment of protein localization | 5.11% (12/235) | 3.49 | 0.0 | 0.0 |
| GO:0044424 | intracellular part | 12.77% (30/235) | 1.86 | 0.0 | 0.0 |
| GO:0006886 | intracellular protein transport | 4.68% (11/235) | 3.76 | 0.0 | 0.0 |
| GO:0044464 | cell part | 13.62% (32/235) | 1.82 | 0.0 | 0.0 |
| GO:0046907 | intracellular transport | 5.11% (12/235) | 3.54 | 0.0 | 0.0 |
| GO:0140096 | catalytic activity, acting on a protein | 12.77% (30/235) | 1.82 | 0.0 | 0.0 |
| GO:0030117 | membrane coat | 2.98% (7/235) | 4.72 | 0.0 | 0.0 |
| GO:0006464 | cellular protein modification process | 10.64% (25/235) | 1.96 | 0.0 | 0.0 |
| GO:0036211 | protein modification process | 10.64% (25/235) | 1.96 | 0.0 | 0.0 |
| GO:0043412 | macromolecule modification | 11.06% (26/235) | 1.91 | 0.0 | 0.0 |
| GO:0071702 | organic substance transport | 5.11% (12/235) | 3.05 | 0.0 | 1e-06 |
| GO:0008270 | zinc ion binding | 5.53% (13/235) | 2.88 | 0.0 | 1e-06 |
| GO:0044260 | cellular macromolecule metabolic process | 14.04% (33/235) | 1.49 | 0.0 | 2e-06 |
| GO:0043170 | macromolecule metabolic process | 16.6% (39/235) | 1.3 | 0.0 | 3e-06 |
| GO:0071705 | nitrogen compound transport | 5.11% (12/235) | 2.82 | 0.0 | 3e-06 |
| GO:0003674 | molecular_function | 48.09% (113/235) | 0.58 | 0.0 | 4e-06 |
| GO:0019538 | protein metabolic process | 12.34% (29/235) | 1.5 | 0.0 | 8e-06 |
| GO:0022406 | membrane docking | 1.7% (4/235) | 5.56 | 1e-06 | 1e-05 |
| GO:0006904 | vesicle docking involved in exocytosis | 1.7% (4/235) | 5.56 | 1e-06 | 1e-05 |
| GO:0140056 | organelle localization by membrane tethering | 1.7% (4/235) | 5.56 | 1e-06 | 1e-05 |
| GO:0140029 | exocytic process | 1.7% (4/235) | 5.56 | 1e-06 | 1e-05 |
| GO:0051640 | organelle localization | 1.7% (4/235) | 5.56 | 1e-06 | 1e-05 |
| GO:0048278 | vesicle docking | 1.7% (4/235) | 5.56 | 1e-06 | 1e-05 |
| GO:0043167 | ion binding | 18.3% (43/235) | 1.13 | 1e-06 | 1.1e-05 |
| GO:0008234 | cysteine-type peptidase activity | 2.98% (7/235) | 3.72 | 1e-06 | 1.2e-05 |
| GO:0044433 | cytoplasmic vesicle part | 2.13% (5/235) | 4.69 | 1e-06 | 1.3e-05 |
| GO:0005515 | protein binding | 15.32% (36/235) | 1.25 | 1e-06 | 1.4e-05 |
| GO:0044267 | cellular protein metabolic process | 10.64% (25/235) | 1.58 | 1e-06 | 1.4e-05 |
| GO:0005086 | ARF guanyl-nucleotide exchange factor activity | 1.28% (3/235) | 6.37 | 2e-06 | 1.9e-05 |
| GO:0051056 | regulation of small GTPase mediated signal transduction | 1.28% (3/235) | 6.37 | 2e-06 | 1.9e-05 |
| GO:1902531 | regulation of intracellular signal transduction | 1.28% (3/235) | 6.37 | 2e-06 | 1.9e-05 |
| GO:0032012 | regulation of ARF protein signal transduction | 1.28% (3/235) | 6.37 | 2e-06 | 1.9e-05 |
| GO:0046578 | regulation of Ras protein signal transduction | 1.28% (3/235) | 6.37 | 2e-06 | 1.9e-05 |
| GO:0005634 | nucleus | 3.83% (9/235) | 2.98 | 2e-06 | 2.2e-05 |
| GO:0019783 | ubiquitin-like protein-specific protease activity | 2.13% (5/235) | 4.44 | 3e-06 | 2.5e-05 |
| GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity | 2.13% (5/235) | 4.44 | 3e-06 | 2.5e-05 |
| GO:0101005 | ubiquitinyl hydrolase activity | 2.13% (5/235) | 4.44 | 3e-06 | 2.5e-05 |
| GO:0009987 | cellular process | 19.57% (46/235) | 1.02 | 2e-06 | 2.6e-05 |
| GO:0016740 | transferase activity | 14.04% (33/235) | 1.26 | 3e-06 | 2.9e-05 |
| GO:0016772 | transferase activity, transferring phosphorus-containing groups | 8.94% (21/235) | 1.66 | 3e-06 | 3.3e-05 |
| GO:0051179 | localization | 10.21% (24/235) | 1.51 | 4e-06 | 4.1e-05 |
| GO:0044444 | cytoplasmic part | 6.38% (15/235) | 2.02 | 5e-06 | 4.7e-05 |
| GO:0006807 | nitrogen compound metabolic process | 16.17% (38/235) | 1.11 | 6e-06 | 5.1e-05 |
| GO:0005085 | guanyl-nucleotide exchange factor activity | 1.28% (3/235) | 5.95 | 7e-06 | 6e-05 |
| GO:0030120 | vesicle coat | 1.7% (4/235) | 4.78 | 1e-05 | 8.2e-05 |
| GO:0019899 | enzyme binding | 2.13% (5/235) | 4.05 | 1.1e-05 | 9.1e-05 |
| GO:0098796 | membrane protein complex | 3.83% (9/235) | 2.68 | 1.2e-05 | 9.7e-05 |
| GO:0032991 | protein-containing complex | 8.09% (19/235) | 1.65 | 1.2e-05 | 0.0001 |
| GO:0099023 | tethering complex | 1.7% (4/235) | 4.67 | 1.4e-05 | 0.000109 |
| GO:0043231 | intracellular membrane-bounded organelle | 3.83% (9/235) | 2.62 | 1.7e-05 | 0.000128 |
| GO:0043227 | membrane-bounded organelle | 3.83% (9/235) | 2.62 | 1.7e-05 | 0.000128 |
| GO:0005575 | cellular_component | 16.17% (38/235) | 1.04 | 1.7e-05 | 0.000128 |
| GO:0070011 | peptidase activity, acting on L-amino acid peptides | 4.26% (10/235) | 2.35 | 2.9e-05 | 0.000214 |
| GO:0023051 | regulation of signaling | 1.28% (3/235) | 5.37 | 3.4e-05 | 0.00023 |
| GO:0004843 | thiol-dependent ubiquitin-specific protease activity | 1.28% (3/235) | 5.37 | 3.4e-05 | 0.00023 |
| GO:0010646 | regulation of cell communication | 1.28% (3/235) | 5.37 | 3.4e-05 | 0.00023 |
| GO:0009966 | regulation of signal transduction | 1.28% (3/235) | 5.37 | 3.4e-05 | 0.00023 |
| GO:0016301 | kinase activity | 7.23% (17/235) | 1.64 | 3.8e-05 | 0.000241 |
| GO:0044237 | cellular metabolic process | 16.17% (38/235) | 0.99 | 3.8e-05 | 0.000243 |
| GO:0070646 | protein modification by small protein removal | 1.7% (4/235) | 4.37 | 3.4e-05 | 0.000244 |
| GO:0016579 | protein deubiquitination | 1.7% (4/235) | 4.37 | 3.4e-05 | 0.000244 |
| GO:0006810 | transport | 9.36% (22/235) | 1.4 | 3.7e-05 | 0.000245 |
| GO:0051234 | establishment of localization | 9.36% (22/235) | 1.39 | 3.8e-05 | 0.000246 |
| GO:0070647 | protein modification by small protein conjugation or removal | 2.55% (6/235) | 3.23 | 4.2e-05 | 0.000265 |
| GO:0044431 | Golgi apparatus part | 1.7% (4/235) | 4.28 | 4.4e-05 | 0.00027 |
| GO:0008233 | peptidase activity | 4.26% (10/235) | 2.28 | 4.4e-05 | 0.000271 |
| GO:0051020 | GTPase binding | 1.7% (4/235) | 4.2 | 5.6e-05 | 0.000334 |
| GO:0000145 | exocyst | 1.28% (3/235) | 5.15 | 5.9e-05 | 0.000335 |
| GO:0048583 | regulation of response to stimulus | 1.28% (3/235) | 5.15 | 5.9e-05 | 0.000335 |
| GO:0044448 | cell cortex part | 1.28% (3/235) | 5.15 | 5.9e-05 | 0.000335 |
| GO:0044238 | primary metabolic process | 17.45% (41/235) | 0.91 | 5.7e-05 | 0.000336 |
| GO:1901564 | organonitrogen compound metabolic process | 12.34% (29/235) | 1.14 | 5.5e-05 | 0.000336 |
| GO:0046872 | metal ion binding | 8.51% (20/235) | 1.41 | 7.5e-05 | 0.00042 |
| GO:0043169 | cation binding | 8.51% (20/235) | 1.4 | 8e-05 | 0.000443 |
| GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 6.81% (16/235) | 1.58 | 0.000105 | 0.000576 |
| GO:0048193 | Golgi vesicle transport | 1.7% (4/235) | 3.98 | 0.000106 | 0.000576 |
| GO:0004672 | protein kinase activity | 6.38% (15/235) | 1.62 | 0.000124 | 0.000665 |
| GO:0044446 | intracellular organelle part | 4.68% (11/235) | 1.96 | 0.000133 | 0.000694 |
| GO:0044422 | organelle part | 4.68% (11/235) | 1.96 | 0.000133 | 0.000694 |
| GO:0008150 | biological_process | 30.64% (72/235) | 0.58 | 0.000144 | 0.000743 |
| GO:0071704 | organic substance metabolic process | 17.45% (41/235) | 0.84 | 0.000171 | 0.000876 |
| GO:0006793 | phosphorus metabolic process | 7.23% (17/235) | 1.41 | 0.000258 | 0.00129 |
| GO:0006796 | phosphate-containing compound metabolic process | 7.23% (17/235) | 1.41 | 0.000258 | 0.00129 |
| GO:0030126 | COPI vesicle coat | 0.85% (2/235) | 5.78 | 0.000434 | 0.002101 |
| GO:0030131 | clathrin adaptor complex | 0.85% (2/235) | 5.78 | 0.000434 | 0.002101 |
| GO:0046914 | transition metal ion binding | 5.53% (13/235) | 1.59 | 0.000432 | 0.002136 |
| GO:0016570 | histone modification | 1.28% (3/235) | 4.25 | 0.000457 | 0.002169 |
| GO:0016569 | covalent chromatin modification | 1.28% (3/235) | 4.25 | 0.000457 | 0.002169 |
| GO:0016310 | phosphorylation | 5.96% (14/235) | 1.5 | 0.000474 | 0.002225 |
| GO:0046488 | phosphatidylinositol metabolic process | 1.28% (3/235) | 4.15 | 0.000577 | 0.002681 |
| GO:0005524 | ATP binding | 8.51% (20/235) | 1.16 | 0.000714 | 0.003285 |
| GO:0006468 | protein phosphorylation | 5.53% (13/235) | 1.5 | 0.000791 | 0.003604 |
| GO:0035639 | purine ribonucleoside triphosphate binding | 9.36% (22/235) | 1.08 | 0.000828 | 0.003733 |
| GO:0030119 | AP-type membrane coat adaptor complex | 0.85% (2/235) | 5.37 | 0.000861 | 0.003845 |
| GO:0006650 | glycerophospholipid metabolic process | 1.28% (3/235) | 3.95 | 0.000872 | 0.003856 |
| GO:0046486 | glycerolipid metabolic process | 1.28% (3/235) | 3.87 | 0.001049 | 0.004597 |
| GO:0006508 | proteolysis | 3.4% (8/235) | 1.96 | 0.001114 | 0.004835 |
| GO:0032559 | adenyl ribonucleotide binding | 8.51% (20/235) | 1.08 | 0.00135 | 0.005804 |
| GO:0030554 | adenyl nucleotide binding | 8.51% (20/235) | 1.08 | 0.001392 | 0.005928 |
| GO:0035091 | phosphatidylinositol binding | 0.85% (2/235) | 5.05 | 0.001423 | 0.005952 |
| GO:0043015 | gamma-tubulin binding | 0.85% (2/235) | 5.05 | 0.001423 | 0.005952 |
| GO:0043168 | anion binding | 10.21% (24/235) | 0.96 | 0.001486 | 0.006101 |
| GO:0032555 | purine ribonucleotide binding | 9.36% (22/235) | 1.01 | 0.001479 | 0.006128 |
| GO:0003676 | nucleic acid binding | 8.09% (19/235) | 1.1 | 0.001546 | 0.006295 |
| GO:0017076 | purine nucleotide binding | 9.36% (22/235) | 1.0 | 0.001563 | 0.006308 |
| GO:0032553 | ribonucleotide binding | 9.36% (22/235) | 1.0 | 0.001675 | 0.006698 |
| GO:0008144 | drug binding | 8.51% (20/235) | 1.05 | 0.001715 | 0.006744 |
| GO:0008289 | lipid binding | 1.28% (3/235) | 3.63 | 0.001713 | 0.006791 |
| GO:0030127 | COPII vesicle coat | 0.85% (2/235) | 4.78 | 0.002118 | 0.008187 |
| GO:0097367 | carbohydrate derivative binding | 9.36% (22/235) | 0.97 | 0.002105 | 0.008207 |
| GO:0006325 | chromatin organization | 1.28% (3/235) | 3.31 | 0.003305 | 0.012668 |
| GO:0098772 | molecular function regulator | 1.7% (4/235) | 2.7 | 0.003345 | 0.012717 |
| GO:0005543 | phospholipid binding | 0.85% (2/235) | 4.37 | 0.003891 | 0.01467 |
| GO:0097159 | organic cyclic compound binding | 15.74% (37/235) | 0.62 | 0.005658 | 0.020333 |
| GO:1901363 | heterocyclic compound binding | 15.74% (37/235) | 0.62 | 0.005658 | 0.020333 |
| GO:0044451 | nucleoplasm part | 1.28% (3/235) | 3.05 | 0.00558 | 0.020373 |
| GO:0006644 | phospholipid metabolic process | 1.28% (3/235) | 3.05 | 0.00558 | 0.020373 |
| GO:1901265 | nucleoside phosphate binding | 9.36% (22/235) | 0.85 | 0.005551 | 0.020593 |
| GO:0000166 | nucleotide binding | 9.36% (22/235) | 0.85 | 0.005551 | 0.020593 |
| GO:0006661 | phosphatidylinositol biosynthetic process | 0.85% (2/235) | 3.91 | 0.007462 | 0.024518 |
| GO:0006888 | ER to Golgi vesicle-mediated transport | 0.85% (2/235) | 3.91 | 0.007462 | 0.024518 |
| GO:0018024 | histone-lysine N-methyltransferase activity | 0.85% (2/235) | 3.91 | 0.007462 | 0.024518 |
| GO:0016279 | protein-lysine N-methyltransferase activity | 0.85% (2/235) | 3.91 | 0.007462 | 0.024518 |
| GO:0018205 | peptidyl-lysine modification | 0.85% (2/235) | 3.91 | 0.007462 | 0.024518 |
| GO:0006506 | GPI anchor biosynthetic process | 0.85% (2/235) | 3.91 | 0.007462 | 0.024518 |
| GO:0006497 | protein lipidation | 0.85% (2/235) | 3.91 | 0.007462 | 0.024518 |
| GO:0006505 | GPI anchor metabolic process | 0.85% (2/235) | 3.91 | 0.007462 | 0.024518 |
| GO:0016278 | lysine N-methyltransferase activity | 0.85% (2/235) | 3.91 | 0.007462 | 0.024518 |
| GO:0042054 | histone methyltransferase activity | 0.85% (2/235) | 3.91 | 0.007462 | 0.024518 |
| GO:0050789 | regulation of biological process | 3.83% (9/235) | 1.42 | 0.006936 | 0.024732 |
| GO:0003824 | catalytic activity | 23.83% (56/235) | 0.45 | 0.007144 | 0.025278 |
| GO:0016043 | cellular component organization | 2.55% (6/235) | 1.77 | 0.008496 | 0.027716 |
| GO:0004674 | protein serine/threonine kinase activity | 0.85% (2/235) | 3.78 | 0.008883 | 0.028576 |
| GO:0008276 | protein methyltransferase activity | 0.85% (2/235) | 3.78 | 0.008883 | 0.028576 |
| GO:0008237 | metallopeptidase activity | 1.28% (3/235) | 2.78 | 0.009306 | 0.029729 |
| GO:0036094 | small molecule binding | 9.36% (22/235) | 0.78 | 0.009439 | 0.029943 |
| GO:0046474 | glycerophospholipid biosynthetic process | 0.85% (2/235) | 3.67 | 0.010415 | 0.032816 |
| GO:0016050 | vesicle organization | 0.43% (1/235) | 6.37 | 0.0121 | 0.033734 |
| GO:0019107 | myristoyltransferase activity | 0.43% (1/235) | 6.37 | 0.0121 | 0.033734 |
| GO:0048284 | organelle fusion | 0.43% (1/235) | 6.37 | 0.0121 | 0.033734 |
| GO:0048280 | vesicle fusion with Golgi apparatus | 0.43% (1/235) | 6.37 | 0.0121 | 0.033734 |
| GO:0000159 | protein phosphatase type 2A complex | 0.43% (1/235) | 6.37 | 0.0121 | 0.033734 |
| GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity | 0.43% (1/235) | 6.37 | 0.0121 | 0.033734 |
| GO:0035658 | Mon1-Ccz1 complex | 0.43% (1/235) | 6.37 | 0.0121 | 0.033734 |
| GO:0090174 | organelle membrane fusion | 0.43% (1/235) | 6.37 | 0.0121 | 0.033734 |
| GO:1990380 | Lys48-specific deubiquitinase activity | 0.43% (1/235) | 6.37 | 0.0121 | 0.033734 |
| GO:0061025 | membrane fusion | 0.43% (1/235) | 6.37 | 0.0121 | 0.033734 |
| GO:0048365 | Rac GTPase binding | 0.43% (1/235) | 6.37 | 0.0121 | 0.033734 |
| GO:0006906 | vesicle fusion | 0.43% (1/235) | 6.37 | 0.0121 | 0.033734 |
| GO:0004677 | DNA-dependent protein kinase activity | 0.43% (1/235) | 6.37 | 0.0121 | 0.033734 |
| GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity | 0.43% (1/235) | 6.37 | 0.0121 | 0.033734 |
| GO:0016779 | nucleotidyltransferase activity | 1.7% (4/235) | 2.22 | 0.010787 | 0.033755 |
| GO:0065007 | biological regulation | 3.83% (9/235) | 1.31 | 0.010869 | 0.033782 |
| GO:0043229 | intracellular organelle | 3.83% (9/235) | 1.3 | 0.011777 | 0.036359 |
| GO:0045017 | glycerolipid biosynthetic process | 0.85% (2/235) | 3.56 | 0.012055 | 0.036725 |
| GO:0043226 | organelle | 3.83% (9/235) | 1.29 | 0.012013 | 0.03684 |
| GO:0035251 | UDP-glucosyltransferase activity | 0.85% (2/235) | 3.46 | 0.0138 | 0.038012 |
| GO:0008170 | N-methyltransferase activity | 0.85% (2/235) | 3.46 | 0.0138 | 0.038012 |
| GO:0050794 | regulation of cellular process | 3.4% (8/235) | 1.34 | 0.014422 | 0.039489 |
| GO:1903509 | liposaccharide metabolic process | 0.85% (2/235) | 3.37 | 0.015647 | 0.041846 |
| GO:0046467 | membrane lipid biosynthetic process | 0.85% (2/235) | 3.37 | 0.015647 | 0.041846 |
| GO:0006664 | glycolipid metabolic process | 0.85% (2/235) | 3.37 | 0.015647 | 0.041846 |
| GO:0009247 | glycolipid biosynthetic process | 0.85% (2/235) | 3.37 | 0.015647 | 0.041846 |
| GO:0006643 | membrane lipid metabolic process | 0.85% (2/235) | 3.28 | 0.017593 | 0.046779 |
| GO:0004842 | ubiquitin-protein transferase activity | 1.28% (3/235) | 2.43 | 0.018119 | 0.047356 |
| GO:0019787 | ubiquitin-like protein transferase activity | 1.28% (3/235) | 2.43 | 0.018119 | 0.047356 |
| GO:0090304 | nucleic acid metabolic process | 4.26% (10/235) | 1.11 | 0.018319 | 0.047608 |
| GO:0140098 | catalytic activity, acting on RNA | 2.13% (5/235) | 1.72 | 0.018073 | 0.04778 |
| GO:0032774 | RNA biosynthetic process | 1.7% (4/235) | 1.98 | 0.018985 | 0.049061 |